AI filing briefs · archive

8-K filings in April 2026, explained

1,298 material Form 8-K filings that 1,057 companies we cover made with the SEC in April 2026, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).

Clear

4 of 1,298 briefs match

newest first · times in ET
OVVOvintiv Inc. Apr 9, 5:04 PM ET

Ovintiv completes $2.9 billion Anadarko asset sale, to redeem $700 million notes

Positive m&a Written later 1.022.017.018.01

Ovintiv closed the sale of its Anadarko assets in Oklahoma on April 9, 2026, with the buyer paying $2.9 billion in cash after preliminary closing adjustments. The company said proceeds will go to debt reduction and that the sale achieves its debt target. Ovintiv also plans to repay C$1.57 billion under its Credit Agreement on April 10, 2026 and redeem $700 million of 5.650% notes due 2028 on April 20, 2026.

  • Buyer MidCon II BuyerCo, LLC paid $2.9 billion in cash after preliminary closing adjustments; the press release cites expected proceeds of about $2.85 billion after customary adjustments
  • Sold approximately 360,000 net acres in west-central Oklahoma, with an effective date of January 1, 2026
  • Credit Agreement borrowings of C$1.57 billion to be repaid April 10, 2026, after which the agreement terminates
  • $700 million aggregate principal of 5.650% notes due 2028 to be redeemed April 20, 2026
Read the filing on SEC.gov ↗
WDFCWD 40 CO Apr 9, 4:07 PM ET

WD-40 Q2 net sales rise 11% to $161.7 million; fiscal 2026 guidance reaffirmed

Positive earnings Written later 2.02

WD-40 reported second-quarter fiscal 2026 results for the quarter ended February 28, 2026, with net sales up 11% to $161.7 million and non-GAAP adjusted diluted EPS up 14% to $1.50. GAAP diluted EPS fell 32% to $1.50 from $2.19, mainly because the prior-year quarter included an $11.9 million one-time tax benefit, and management reaffirmed its full-year fiscal 2026 guidance.

  • Total net sales were $161.7 million, up 11% from the prior-year quarter; on a constant currency basis, sales rose 4%.
  • Maintenance product sales rose 13% to $156.8 million, or 6% in constant currency.
  • GAAP diluted EPS was $1.50 versus $2.19; excluding the prior-year $11.9 million tax benefit, adjusted EPS rose 14%.
  • Management reaffirmed fiscal 2026 guidance, including diluted EPS of $5.75 to $6.15, and the company repurchased $8.0 million of shares in the quarter.
Read the filing on SEC.gov ↗
BKEBUCKLE INC Apr 9, 12:38 PM ET

Buckle March net sales rise 8.2% to $118.0 million; Scott Werth named SVP of Stores

Positive earnings Written later 5.02

Buckle reported that net sales for the 5-week period ended April 4, 2026 rose 8.2% to $118.0 million, and comparable store net sales rose 7.0%. The company also appointed Scott A. Werth as Senior Vice President of Stores, effective March 31, 2026, to lead its sales team of more than 7,000 teammates across 42 states.

  • 5-week fiscal month net sales increased 8.2% to $118.0 million from $109.1 million a year earlier
  • Comparable store net sales rose 7.0% for the 5-week period ended April 4, 2026
  • 9-week year-to-date net sales increased 8.5% to $202.5 million from $186.6 million
  • Scott A. Werth, a Buckle employee since June 1989 and most recently Vice President of Sales and Strategy, was appointed SVP of Stores effective March 31, 2026
Read the filing on SEC.gov ↗

Treace Medical lifts 2026 revenue guidance low end to $202 million; CCO departs

Positive guidance Written later 2.025.027.01

Treace Medical preliminarily reported first-quarter 2026 revenue of $47.0 million to $47.2 million and cash of about $51.9 million, and raised the low end of its full-year 2026 revenue guidance to $202 million to $212 million. The company also said Chief Commercial Officer Gaetano M. Guglielmino departed effective April 8, 2026, and will not be replaced, with his duties moved to existing staff and the head of sales reporting to the CEO.

  • Preliminary Q1 2026 revenue: $47.0 million to $47.2 million (unaudited; subject to financial closing procedures)
  • Cash, equivalents and marketable securities about $51.9 million at March 31, 2026, up about $3.5 million from $48.4 million at December 31, 2025
  • 2026 revenue guidance updated to $202 million to $212 million, from $200 million to $212 million previously
  • Chief Commercial Officer Gaetano M. Guglielmino departed April 8, 2026; consulting agreement runs through January 31, 2027 at a monthly fee of $36,666.67
Read the filing on SEC.gov ↗

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.

Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.